Beth Wallace, MD, MS

home / authors / beth-wallace-md-ms

Articles

July 8th 2025

Corticosteroid Premedication for Infliximab Remains Unnecessarily Common

Shirley Cohen-Mekelburg, MD, MS Jeffrey Gibbs, MD Beth Wallace, MD, MS Brooke Kenney, MPH Akbar K. Waljee, MD, MSc

Although use of corticosteroid premedication prior to infliximab infusions is declining, it remains unnecessarily high despite limited benefit and the risk of serious adverse events from corticosteroids.

October 7th 2019

Inflammatory Bowel Disease Readmissions Are Associated With Utilization and Comorbidity

Shirley Cohen-Mekelburg, MD, MS Russell Rosenblatt, MD, MS Beth Wallace, MD, MS Nicole Shen, MD, MS Brett Fortune, MD, MSc Akbar K. Waljee, MD, MSc Sameer Saini, MD, MS Ellen Scherl, MD Robert Burakoff, MD Mark Unruh, PhD

Thirty-day readmissions related to inflammatory bowel disease are common and associated with longer length of stay and a higher likelihood of having an associated comorbid condition compared with index hospitalizations.